These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7297773)

  • 21. Diabetes, hyperglycemia, and coronary heart disease.
    Rose G
    Prev Med; 1983 Jan; 12(1):70-4. PubMed ID: 6844320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral glucose-tolerance tests and the diagnosis of diabetes: results of a prospective study based on the Whitehall survey.
    Sayegh HA; Jarrett RJ
    Lancet; 1979 Sep; 2(8140):431-3. PubMed ID: 89497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymptomatic hyperglycemia and atherosclerotic vascular disease in the elderly.
    Mykkänen L; Laakso M; Pyörälä K
    Diabetes Care; 1992 Aug; 15(8):1020-30. PubMed ID: 1505303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atherosclerosis, diabetes and obesity.
    Jarrett RJ
    Proc Nutr Soc; 1981 May; 40(2):209-12. PubMed ID: 7017741
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of antihypertensive drugs on glucose intolerance in hypertensive nondiabetics and diabetics.
    Houston MC
    Am Heart J; 1988 Mar; 115(3):640-56. PubMed ID: 3278578
    [No Abstract]   [Full Text] [Related]  

  • 26. Impaired glucose tolerance and its relationship to ECG-indicated coronary heart disease and risk factors among Chinese. Da Qing IGT and diabetes study.
    Pan XR; Hu YH; Li GW; Liu PA; Bennett PH; Howard BV
    Diabetes Care; 1993 Jan; 16(1):150-6. PubMed ID: 8422770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.
    Fuller JH; Shipley MJ; Rose G; Jarrett RJ; Keen H
    Lancet; 1980 Jun; 1(8183):1373-6. PubMed ID: 6104171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later.
    Eschwege E; Richard JL; Thibult N; Ducimetière P; Warnet JM; Claude JR; Rosselin GE
    Horm Metab Res Suppl; 1985; 15():41-6. PubMed ID: 3908280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obesity and nutrition in elderly diabetic patients.
    Kannel WB; Garrison RJ; Wilson PW
    Am J Med; 1986 May; 80(5A):22-30. PubMed ID: 3706387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyperglycemia, diabetes and coronary heart disease.
    Epstein FH
    G Ital Cardiol; 1974; 4(2):223-9. PubMed ID: 4838125
    [No Abstract]   [Full Text] [Related]  

  • 31. [Profile of the main risk factors of arteriosclerosis in patients with diabetes mellitus].
    Tatoń J; Walewski J
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):3-7. PubMed ID: 1409038
    [No Abstract]   [Full Text] [Related]  

  • 32. Peripheral arterial disease and its relationship to cardiovascular risk factors and coronary heart disease in newly diagnosed non-insulin-dependent diabetics.
    Siitonen O; Uusitupa M; Pyörälä K; Voutilainen E; Länsimies E
    Acta Med Scand; 1986; 220(3):205-12. PubMed ID: 3776696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glucose tolerance test and immunoreactive insulin level in the blood of the relatives of patients with coronary arteriosclerosis].
    Kovalev IuR; Dzeranova NIa
    Ter Arkh; 1984; 56(1):76-81. PubMed ID: 6369606
    [No Abstract]   [Full Text] [Related]  

  • 34. The relationships between PON1 activity as well as oxLDL levels and coronary artery lesions in CHD patients with diabetes mellitus or impaired fasting glucose.
    Lu C; Gao Y; Zhou H; Tian H
    Coron Artery Dis; 2008 Dec; 19(8):565-73. PubMed ID: 19005291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors.
    Temelkova-Kurktschiev TS; Koehler C; Leonhardt W; Schaper F; Henkel E; Siegert G; Hanefeld M
    Diabetes Care; 1999 Feb; 22(2):333-8. PubMed ID: 10333954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [General concept and pathophysiological mechanisms of progression of macrovascular complications in diabetes].
    Kashiwagi A
    Nihon Rinsho; 2010 May; 68(5):777-87. PubMed ID: 20446569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes.
    Haffner SM
    Diabetes Care; 1999 Apr; 22 Suppl 3():C54-6. PubMed ID: 10189563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Significance of postprandial glucose peaks for development of diabetic macroangiopathy].
    Temelkova-Kurktschiev T
    Ther Umsch; 2002 Aug; 59(8):411-4. PubMed ID: 12235733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis.
    Niskanen L; Turpeinen A; Penttilä I; Uusitupa MI
    Diabetes Care; 1998 Nov; 21(11):1861-9. PubMed ID: 9802734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hyperglycemia and cardiovascular events].
    Schneider CA; Gallwitz B; Hanefeld M; Leschke M; Müller-Wieland D; Zeymer U; Erdmann E
    Dtsch Med Wochenschr; 2004 Nov; 129(47):2553-7. PubMed ID: 15543474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.